Name | Number of supported studies | Average coverage | |
---|---|---|---|
pancreatic A cell | 3 studies | 25% ± 2% | |
type B pancreatic cell | 3 studies | 39% ± 12% | |
retinal bipolar neuron | 3 studies | 35% ± 12% | |
retinal ganglion cell | 3 studies | 52% ± 26% | |
amacrine cell | 3 studies | 42% ± 14% | |
retinal cone cell | 3 studies | 49% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 3664.24 | 2603 / 2642 | 98% | 78.93 | 694 / 705 |
adrenal gland | 95% | 2050.81 | 245 / 258 | 91% | 143.99 | 209 / 230 |
muscle | 100% | 13479.19 | 803 / 803 | 0% | 0 | 0 / 0 |
heart | 95% | 2765.81 | 821 / 861 | 0% | 0 | 0 / 0 |
ovary | 84% | 1357.56 | 152 / 180 | 9% | 0.43 | 39 / 430 |
blood vessel | 91% | 2472.10 | 1214 / 1335 | 0% | 0 | 0 / 0 |
prostate | 11% | 114.60 | 28 / 245 | 59% | 3.77 | 298 / 502 |
pancreas | 1% | 5.13 | 2 / 328 | 70% | 13.92 | 124 / 178 |
eye | 0% | 0 | 0 / 0 | 33% | 3.02 | 26 / 80 |
lung | 13% | 100.08 | 74 / 578 | 13% | 0.56 | 149 / 1155 |
stomach | 11% | 88.14 | 41 / 359 | 14% | 0.70 | 40 / 286 |
uterus | 6% | 50.80 | 10 / 170 | 16% | 1.82 | 74 / 459 |
tonsil | 0% | 0 | 0 / 0 | 18% | 3.25 | 8 / 45 |
esophagus | 9% | 65.75 | 124 / 1445 | 6% | 0.23 | 11 / 183 |
thymus | 1% | 10.99 | 8 / 653 | 13% | 0.58 | 80 / 605 |
intestine | 6% | 46.35 | 58 / 966 | 7% | 0.59 | 39 / 527 |
kidney | 1% | 7.96 | 1 / 89 | 7% | 0.43 | 59 / 901 |
liver | 0% | 0 | 0 / 226 | 6% | 0.56 | 24 / 406 |
skin | 0% | 4.31 | 4 / 1809 | 5% | 0.20 | 22 / 472 |
bladder | 0% | 0 | 0 / 21 | 4% | 0.81 | 22 / 504 |
breast | 0% | 3.25 | 2 / 459 | 4% | 0.41 | 40 / 1118 |
peripheral blood | 1% | 13.78 | 9 / 929 | 0% | 0 | 0 / 0 |
adipose | 1% | 8.17 | 10 / 1204 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0043409 | Biological process | negative regulation of MAPK cascade |
GO_0070373 | Biological process | negative regulation of ERK1 and ERK2 cascade |
GO_0006470 | Biological process | protein dephosphorylation |
GO_0045785 | Biological process | positive regulation of cell adhesion |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0004725 | Molecular function | protein tyrosine phosphatase activity |
GO_0017018 | Molecular function | myosin phosphatase activity |
GO_0004721 | Molecular function | phosphoprotein phosphatase activity |
GO_0005515 | Molecular function | protein binding |
GO_0008138 | Molecular function | protein tyrosine/serine/threonine phosphatase activity |
GO_0033549 | Molecular function | MAP kinase phosphatase activity |
GO_0002039 | Molecular function | p53 binding |
Gene name | DUSP26 |
Protein name | Dual specificity protein phosphatase (EC 3.1.3.16) (EC 3.1.3.48) Dual specificity protein phosphatase 26 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity phosphatase SKRP3) (Low-molecular-mass dual-specificity phosphatase 4) (DSP-4) (LDP-4) (Mitogen-activated protein kinase phosphatase 8) (MAP kinase phosphatase 8) (MKP-8) (Novel amplified gene in thyroid anaplastic cancer) |
Synonyms | LDP4 MKP8 SKRP3 DUSP24 NATA1 |
Description | FUNCTION: Inactivates MAPK1 and MAPK3 which leads to dephosphorylation of heat shock factor protein 4 and a reduction in its DNA-binding activity. Inhibits MAP kinase p38 by dephosphorylating it and inhibits p38-mediated apoptosis in anaplastic thyroid cancer cells. Can also induce activation of MAP kinase p38 and c-Jun N-terminal kinase (JNK). . FUNCTION: Dual specificity phosphatase able to dephosphorylate phosphotyrosine, phosphoserine and phosphothreonine residues, with a preference for phosphotyrosine as a substrate. . |
Accessions | Q9BV47 E5RHD0 ENST00000523956.1 [Q9BV47-1] ENST00000522982.1 ENST00000256261.9 [Q9BV47-1] |